Legacy Wealth Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Legacy Wealth Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,231	Closed	-$368K	–	344
2022 Q4	$368K	Sell	3,231 -167	-5%	-$13.9K	0.14%	268
2022 Q3	$210K	Sell	3,398 -28	-0.8%	-$1.96K	0.09%	303
2022 Q2	$273K	Buy	3,426 +3	+0.1%	+$284	0.11%	244
2022 Q1	$360K	Buy	3,423 +37	+1%	+$3.61K	0.13%	225
2021 Q4	$365K	Sell	3,386 -94	-3%	-$10.3K	0.12%	237
2021 Q3	$381K	Sell	3,480 -89	-2%	-$9.24K	0.17%	212
2021 Q2	$334K	Sell	3,569 -213	-6%	-$19.6K	0.15%	231
2021 Q1	$348K	Sell	3,782 -29	-0.8%	-$2.45K	0.16%	221
2020 Q4	$279K	Buy	+3,811	New	+$283K	0.14%	241

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legacy Wealth Asset Management's HZNP Position: Q1 2023 in Review

Legacy Wealth Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 3,231 shares — an estimated $368K sold.

Legacy Wealth Asset Management first reported a position in HZNP in Q4 2020 and held it in 9 quarters. The position peaked at $381K in Q3 2021. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Legacy Wealth Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Legacy Wealth Asset Management sold 3,231 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $368K.
Legacy Wealth Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 9 quarters.
Legacy Wealth Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $381K in Q3 2021.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Legacy Wealth Asset Management's 13F filing for Q1 2023, filed 24 Apr 2023.